Terms: = Brain cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Treatment
669 results:
1. Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas.
Davison MA; Lilly DT; Patel AA; Kashkoush A; Chen X; Wei W; Benzel EC; Prayson RA; Chao S; Angelov L
J Neurooncol; 2024 May; 167(3):437-446. PubMed ID: 38438766
[TBL] [Abstract] [Full Text] [Related]
2. Long-term outcomes of multidisciplinary treatment combining surgery and stereotactic radiotherapy with Novalis for craniopharyngioma.
Shinojima N; Yano S; Uchida D; Mizukami N; Mabe H; Kawashima J; Igata M; Kondo T; Uetani H; Yamamoto T; Uekawa K; Hide T; Mikami Y; Hirai T; Mukasa A
J Clin Neurosci; 2024 Feb; 120():138-146. PubMed ID: 38244528
[TBL] [Abstract] [Full Text] [Related]
3. Outer Membrane Vesicles Released from Garlic Exosome-like Nanoparticles (Gaelns) Train Gut Bacteria that Reverses Type 2 Diabetes via the Gut-brain Axis.
Sundaram K; Teng Y; Mu J; Xu Q; Xu F; Sriwastva MK; Zhang L; Park JW; Zhang X; Yan J; Zhang SQ; Merchant ML; Chen SY; McClain CJ; Dryden GW; Zhang HG
Small; 2024 May; 20(20):e2308680. PubMed ID: 38225709
[TBL] [Abstract] [Full Text] [Related]
4. Association of county-level socioeconomic status with meningioma incidence and outcomes.
Pugazenthi S; Price M; De La Vega Gomar R; Kruchko C; Waite KA; Barnholtz-Sloan JS; Walsh KM; Kim AH; Ostrom QT
Neuro Oncol; 2024 Apr; 26(4):749-763. PubMed ID: 38087980
[TBL] [Abstract] [Full Text] [Related]
5. treatment Course and Outcomes of Intracranial Teratomas in Pediatric Patients: A Retrospective 15-Year Case Series Study.
Wu A; Jin MC; Vogel H; Hiniker S; Campen C; Prolo LM; Grant GA
Pediatr Neurosurg; 2023; 58(6):429-438. PubMed ID: 37879310
[TBL] [Abstract] [Full Text] [Related]
6. Association between county-level socioeconomic status and the incidence of and surgical treatment for pituitary adenoma.
Cote DJ; Kruchko C; Barnholtz-Sloan JS; Zada G; Wiemels JL; Ostrom QT
J Neurosurg; 2024 Mar; 140(3):724-734. PubMed ID: 37877990
[TBL] [Abstract] [Full Text] [Related]
7. Deep wavelet scattering orthogonal fusion network for glioma IDH mutation status prediction.
Chen Q; Wang L; Xing Z; Wang L; Hu X; Wang R; Zhu YM
Comput Biol Med; 2023 Nov; 166():107493. PubMed ID: 37774558
[TBL] [Abstract] [Full Text] [Related]
8. Comparing presentations and outcomes of children with cancer: a study between a lower-middle-income country and a high-income country.
Farrag A; Ghazaly MH; Mohammed K; Volland R; Hero B; Berthold F
BMC Pediatr; 2023 Sep; 23(1):443. PubMed ID: 37670249
[TBL] [Abstract] [Full Text] [Related]
9. Quality of life after surgery for lower grade gliomas.
Heffernan AE; Wu Y; Benz LS; Verhaak RGW; Kwan BM; Claus EB
Cancer; 2023 Dec; 129(23):3761-3771. PubMed ID: 37599093
[TBL] [Abstract] [Full Text] [Related]
10. Surgical Management of brain Tumors in Infants Under One Year of Age.
Baykal D; Demirkaya M; Khezri MK; Ertekin M; Temuroglu A; Abakay CD; Tolunay S; Sevinir B; Taskapilioglu MO
Turk Neurosurg; 2023; 33(5):906-911. PubMed ID: 37528723
[TBL] [Abstract] [Full Text] [Related]
11. Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions.
Roux A; Aboubakr O; Elia A; Moiraghi A; Benevello C; Fathallah H; Parraga E; Oppenheim C; Chretien F; Dezamis E; Zanello M; Pallud J
Neurosurg Rev; 2023 Jun; 46(1):140. PubMed ID: 37329341
[TBL] [Abstract] [Full Text] [Related]
12. Should Redo Surgery be Offered to Patients with Relapsed Glioblastoma? - Outcome Analyses of a Single Institution Comparative Cohort Study.
Eltoukhy M; Kandula V; Joseph S; Albanese E; Giridharan S
World Neurosurg; 2023 Aug; 176():e543-e547. PubMed ID: 37268188
[TBL] [Abstract] [Full Text] [Related]
13. Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.
Weiß S; Thomale UW; Schulz M; Kandels D; Schuhmann MU; El Damaty A; Krauss J; Driever PH; Witt O; Bison B; Pietsch T; Gnekow A; Simon M
Int J Cancer; 2023 Oct; 153(8):1487-1500. PubMed ID: 37260252
[TBL] [Abstract] [Full Text] [Related]
14. Trimodality treatment of Superior Sulcus Non-Small Cell Lung cancer: An Institutional Series of 47 Consecutive Patients.
Rzyman W; Łazar-Poniatowska M; Dziedzic R; Marjański T; Łapiński M; Dziadziuszko R
Curr Oncol; 2023 Apr; 30(5):4551-4562. PubMed ID: 37232802
[TBL] [Abstract] [Full Text] [Related]
15. Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysis.
Ibáñez-Juliá MJ; Picca A; Leclercq D; Berzero G; Jacob J; Feuvret L; Rosso C; Birzu C; Alentorn A; Sanson M; Tafani C; Bompaire F; Bataller L; Hoang-Xuan K; Delattre JY; Psimaras D; Ricard D
J Cancer Surviv; 2024 Feb; 18(1):59-67. PubMed ID: 37142871
[TBL] [Abstract] [Full Text] [Related]
16. Management of Patients with Spine Tumors Strengthened by a Dedicated Multidisciplinary Spine Tumor Board: A 15-Year Single-Institutional Experience.
Mann M; Annable N; Emch TM; Wu J; Chao ST; Benzel E; Winkelman R; Angelov L
World Neurosurg; 2023 Jul; 175():e397-e405. PubMed ID: 37011761
[TBL] [Abstract] [Full Text] [Related]
17. Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series.
Padovan M; Cerretti G; Caccese M; Barbot M; Bergo E; Occhi G; Scaroni C; Lombardi G; Ceccato F
Expert Rev Endocrinol Metab; 2023 Mar; 18(2):181-198. PubMed ID: 36876325
[TBL] [Abstract] [Full Text] [Related]
18. Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
Smolenschi C; Rassy E; Pallud J; Dezamis E; Copaciu R; Parker F; Garcia G; Lezghed N; Colomba E; Khettab M; Ammari S; Fekhi M; Martanovschi L; Benadhou L; Knafo S; Guyon D; Cheaib B; Dhermain F; Dumont SN
J Neurol; 2023 May; 270(5):2702-2714. PubMed ID: 36813928
[TBL] [Abstract] [Full Text] [Related]
19. A retrospective analysis of the prognosis of Japanese patients with sarcoma brain metastasis.
Toda Y; Kobayashi E; Kubota D; Miyakita Y; Narita Y; Kawai A
Cancer Med; 2023 Apr; 12(8):9471-9481. PubMed ID: 36811144
[TBL] [Abstract] [Full Text] [Related]
20. Modeling disrupted synapse formation in wolfram syndrome using hESCs-derived neural cells and cerebral organoids identifies Riluzole as a therapeutic molecule.
Yuan F; Li Y; Hu R; Gong M; Chai M; Ma X; Cha J; Guo P; Yang K; Li M; Xu M; Ma Q; Su Q; Zhang C; Sheng Z; Wu H; Wang Y; Yuan W; Bian S; Shao L; Zhang R; Li K; Shao Z; Zhang ZN; Li W
Mol Psychiatry; 2023 Apr; 28(4):1557-1570. PubMed ID: 36750736
[TBL] [Abstract] [Full Text] [Related]
[Next]
